Healthy participants Trials in Glendale, United States
Conditions / Healthy participants / Glendale, United States
Healthy participants has been the subject of sustained clinical investigation across multiple research sites.
34 total trials for this combination
Showing top 10 of 34 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06469151 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults | COMPLETED | PHASE1 |
| NCT05143905 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants | COMPLETED | PHASE1 |
| NCT07511205 | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. | RECRUITING | — |
| NCT06132841 | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT07300085 | A Trial to Evaluate the Effect of CD388 on the Immunogenicity of Fluzone® HD Vaccine | RECRUITING | PHASE1 |
| NCT06980428 | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia | RECRUITING | — |
| NCT06138795 | A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants | COMPLETED | PHASE1 |
| NCT06349473 | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) | RECRUITING | PHASE1 |
| NCT07290283 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants | RECRUITING | — |
| NCT05511025 | Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese | COMPLETED | PHASE1 |